These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17003661)

  • 21. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder.
    Rynn MA; Siqueland L; Rickels K
    Am J Psychiatry; 2001 Dec; 158(12):2008-14. PubMed ID: 11729017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early improvement is a predictor of treatment outcome in patients with mild major, minor or subsyndromal depression.
    Tadić A; Helmreich I; Mergl R; Hautzinger M; Kohnen R; Henkel V; Hegerl U
    J Affect Disord; 2010 Jan; 120(1-3):86-93. PubMed ID: 19428118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 6-week randomized, placebo-controlled trial of CP-316,311 (a selective CRH1 antagonist) in the treatment of major depression.
    Binneman B; Feltner D; Kolluri S; Shi Y; Qiu R; Stiger T
    Am J Psychiatry; 2008 May; 165(5):617-20. PubMed ID: 18413705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sertraline versus fluvoxamine in the treatment of elderly patients with major depression: a double-blind, randomized trial.
    Rossini D; Serretti A; Franchini L; Mandelli L; Smeraldi E; De Ronchi D; Zanardi R
    J Clin Psychopharmacol; 2005 Oct; 25(5):471-5. PubMed ID: 16160624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Poirot MG; Ruhe HG; Mutsaerts HMM; Maximov II; Groote IR; Bjørnerud A; Marquering HA; Reneman L; Caan MWA
    Am J Psychiatry; 2024 Mar; 181(3):223-233. PubMed ID: 38321916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals.
    Greenberg T; Fournier JC; Stiffler R; Chase HW; Almeida JR; Aslam H; Deckersbach T; Cooper C; Toups MS; Carmody T; Kurian B; Peltier S; Adams P; McInnis MG; Oquendo MA; Fava M; Parsey R; McGrath PJ; Weissman M; Trivedi M; Phillips ML
    Mol Psychiatry; 2020 Jul; 25(7):1526-1536. PubMed ID: 31462766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of pharmacotherapy with electroconvulsive therapy in prevention of depressive relapse: a pilot controlled trial.
    Yildiz A; Mantar A; Simsek S; Onur E; Gökmen N; Fidaner H
    J ECT; 2010 Jun; 26(2):104-10. PubMed ID: 19935091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepines.
    Rapaport MH; Pollack MH; Clary CM; Mardekian J; Wolkow R
    J Clin Psychopharmacol; 2001 Feb; 21(1):104-7. PubMed ID: 11199932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
    J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.
    Ferguson JM; Shrivastava RK; Stahl SM; Hartford JT; Borian F; Ieni J; McQuade RD; Jody D
    J Clin Psychiatry; 2001 Jan; 62(1):24-9. PubMed ID: 11235924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder.
    Zohar J; Amital D; Miodownik C; Kotler M; Bleich A; Lane RM; Austin C
    J Clin Psychopharmacol; 2002 Apr; 22(2):190-5. PubMed ID: 11910265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Solyom AE
    JAMA; 2004 Jan; 291(1):41-2; author reply 42. PubMed ID: 14709569
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Spielmans GI
    JAMA; 2004 Jan; 291(1):41. PubMed ID: 14709570
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Price D
    JAMA; 2004 Jan; 291(1):40-1; author reply 42. PubMed ID: 14709568
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder.
    Mathews M; Mathews M; Mathews J
    JAMA; 2004 Jan; 291(1):40; author reply 42. PubMed ID: 14709567
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sertraline treatment of patients with major depressive disorder who failed initial treatment with paroxetine or fluvoxamine.
    Inoue T; Honda M; Kawamura K; Tsuchiya K; Suzuki T; Ito K; Matsubara R; Shinohara K; Ishikane T; Sasaki K; Boku S; Fujisawa D; Ono Y; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):223-7. PubMed ID: 22504727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.